2014 Researcher Dr. Sheila Singh

Therapeutic targeting of Sox2+ treatment-refractory stem cells in sonic hedgehog-dependent pediatric medulloblastoma

Sheila Singh; MD, PhD, FRCSC, Pediatric Neurosurgeon, Canada Research Chair in Human Cancer Stem Cell Biology, Associate Professor of Surgery, McMaster University
 

Dr. Sheila SinghProject Summary:

Brain tumours represent the leading cause of childhood cancer mortality, of which medulloblastoma (MB) is the most frequent malignant pediatric brain tumour. While MBs characterized by active sonic hedgehog (Shh) signaling have been of therapeutic interest, treatment-resistance has posed significant challenges.

Since MB brain tumour-initiating cells prospectively identify, characterize, and target treatment-refractory BTICs in Shh-dependent MB. In correlating the gene expression profile of 325 human MBs with their overall clinical outcome, we identified the stem cell gene Sox2 as an independent marker of treatment-refractory Shh MB.

By modifying the Children’s Oncology Group (COG) MB protocol for our BTIC human-mouse xenograft model, we will treat Shh-dependent MB BTIC-bearing mice with radio-and chemotherapy and assess the corresponding increase in Sox2+ cells with small molecule inhibitors identified in our pathway network analysis of these cells.

Given the current research emphasis on treatment-naïve tumours, we hope our model will account for the evolution of cells over the course of therapy and provide an opportunity to selectively target and improve the survival of treatment-resistant Group 2 MB patients.

<back to all 2014 Research Grant Awardees
 

Share This

Featured Story

Yaron's Story: 15 years of Hope

Our heartfelt congratulations to Yaron as he reaches a milestone; 15 years on the brain tumour journey! Read his story in his words and see how he is bringing hope to others: This February 23, 2019, it will have been 15 years since I collapsed in a grand mal seizure and was subsequently diagnosed with Glioblastoma (GBM). It’s been quite the adventure since the last time I shared my story...

Learn more

Spotlight

Aaron's Story: I refuse to sink

In the summer of 2017, while at work, I had my first episode of what I would now call vertigo or double vision. It was something I've...

Learn more

Avery's Adventures and Accomplishments Part II

Five years. It has been five years since Avery was first diagnosed with her unfriendly brain tumour, the Juvenile Pilocytic Astrocytoma...

Learn more

Upcoming Events

  • 23/Feb/2019: “Momma ‘C’ Bonspiel”: Montreal West Curling Club... Learn more >
  • 25/Feb/2019: Virtual Support Group for Caregivers: Virtual Support Group for Caregivers... Learn more >
  • 25/Feb/2019: Greater Sudbury Support Group: Meets at The Parkside Centre, 140 Durham Street, Sudbury, Ontario... Learn more >
  • 27/Feb/2019: Toronto Support Group: Meets at Wellspring Westerkirk House at Sunnybrook, Toronto, ON... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2019 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001